Acutaas Chemicals Limited Q2 FY26 earnings call summary

Earnings call of 17 Oct 2025, summarised by AI from the filing.

FY26 revenue growth around 25% and EBITDA margin 28% to 30%, raised on higher CDMO contribution and product mix.

Key takeaways

1. Guidance FY26 revenue growth around 25% and EBITDA margin 28% to 30%, raised on higher CDMO contribution and product mix.
2. Margin change EBITDA margin guidance raised to 28-30% from prior level, driven by CDMO mix and operational efficiency.
3. Growth driver CDMO business drove Pharma Intermediates growth of 27.1% YoY; validation batches dispatched for new products.
4. Risk Global geopolitical and economic landscape remains uncertain, with minor delay in electrolyte capex due to extended rains.

Original filing on BSE

Acutaas Chemicals Limited Q1 FY27 results

As filed: Revenue ₹330 cr (+59% year on year), EBITDA ₹113 cr (+122% year on year), PAT ₹75.0 cr (+70% year on year), EBITDA margin 34.3% (+966 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

• Q4 FY26: Revenue ₹422 cr, EBITDA ₹181 cr, PAT ₹137 cr, EBITDA margin 43.0%. Not scored. No result for the same quarter last year. Share price after the results: +25.2% in 29 days (Nifty 500: −0.9%).
• Q3 FY26: Revenue ₹391 cr, EBITDA ₹154 cr, PAT ₹112 cr, EBITDA margin 39.5%. Not scored. No result for the same quarter last year. Share price after the results: +30.9% in 30 days (Nifty 500: +1.5%).
• Q2 FY26: Revenue ₹305 cr, EBITDA ₹97.0 cr, PAT ₹73.0 cr, EBITDA margin 31.8%. Not scored. No result for the same quarter last year. Share price after the results: +10.2% in 28 days (Nifty 500: +1.2%).
• Q1 FY26: Revenue ₹206 cr, EBITDA ₹51.0 cr, PAT ₹45.0 cr, EBITDA margin 24.8%. Not scored. No result for the same quarter last year. Share price after the results: +20.5% in 30 days (Nifty 500: −2.4%).

Past price moves after results do not indicate future moves. Not a recommendation.

Acutaas Chemicals Limited earnings call, investor presentation and press release summaries

• Q1 FY27: Earnings call (24 Jul 2026), Results deck (24 Jul 2026), Results press release (24 Jul 2026)
• Q4 FY26: Earnings call (30 Apr 2026), Results deck (30 Apr 2026), Results press release (30 Apr 2026)
• Q3 FY26: Earnings call (28 Jan 2026), Results deck (28 Jan 2026), Results press release (28 Jan 2026)
• Q2 FY26: Earnings call (17 Oct 2025), Results deck (17 Oct 2025), Results press release (17 Oct 2025)
• Q1 FY26: Earnings call (30 Jul 2025), Results deck (30 Jul 2025)
• Q4 FY25: Earnings call (2 May 2025), Results deck (2 May 2025), Results press release (2 May 2025)
• Other events: Strategy deck (16 May 2026)